Welcome to our dedicated page for Alignment Healthcare SEC filings (Ticker: ALHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alignment Healthcare, Inc. (NASDAQ: ALHC) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a Medicare Advantage-focused health insurer. Alignment files annual and quarterly reports, along with current reports on Form 8-K, that describe its financial condition, operations and key developments in its Medicare Advantage business.
Recent Form 8-K filings show that Alignment uses these reports to announce quarterly financial results and share information discussed with investors and analysts. For example, the company has filed 8-Ks to furnish press releases on second and third quarter results and to outline discussions of strategy, market position and preliminary CMS Star Ratings. These filings often reference non-GAAP measures such as adjusted gross profit and adjusted EBITDA, which are defined and reconciled to the most comparable GAAP measures in accompanying tables.
Alignment’s SEC filings also provide detail on revenue sources and expenses. Condensed consolidated statements of operations list earned premiums and other revenue, along with medical expenses, selling, general and administrative expenses, and depreciation and amortization. Balance sheet information includes medical expenses payable, long-term debt and stockholders’ equity, giving investors a structured view of the company’s capital and obligations.
Through this page, users can track ongoing 8-K disclosures related to earnings releases, guidance updates, investor presentations and other material events. Filings may also reference CMS Star Ratings, membership expectations and risk factors summarized in the company’s Form 10-K and other periodic reports. Stock Titan enhances access to these documents with AI-powered tools that help explain terminology, highlight key sections and summarize lengthy filings, allowing investors to more quickly understand how ALHC reports its performance, membership trends and risk profile.
Alignment Healthcare, Inc. Chief Information Officer Robert L. Scavo reported selling 4,044 shares of common stock in open-market transactions to cover tax withholding obligations tied to vesting restricted stock units. The sales were not discretionary trades. After these transactions, he continues to hold 498,970 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported selling a total of 29,113 shares of common stock on March 12, 2026 in open-market transactions. Footnotes state these shares were sold solely to cover tax withholding obligations tied to vesting restricted stock units and were not discretionary trades. After these sales, she continues to hold 963,702 shares of Alignment Healthcare common stock directly.
Alignment Healthcare, Inc. Chief Executive Officer John E. Kao reported selling a total of 48,899 shares of common stock in open-market transactions on March 12, 2026. The shares were sold at weighted-average prices of $17.476 and $16.9919 per share.
According to the disclosure, these sales were required to cover tax withholding obligations triggered by the vesting of restricted stock units and did not represent discretionary trading decisions by Mr. Kao. After the transactions, he held 1,519,480 shares directly.
The filing also reports 2,472,641 shares of common stock held indirectly through the JEK Trust, dated February 8, 2021, for which Mr. Kao serves as trustee, providing additional indirect economic exposure to Alignment Healthcare stock.
Alignment Healthcare, Inc. president Dawn Christine Maroney reported a Form 4 showing a bona fide gift of 4,200 shares of common stock to family members on March 10, 2026. The transaction carried no sale price, and she now directly holds 992,815 shares after the gift.
Alignment Healthcare, Inc. notice of sale of 69,541 shares of Common Stock. The filing lists the sale date as
The shares were acquired on
Alignment Healthcare, Inc. submitted a Rule 144 notice relating to planned sales of Common Stock by a selling holder under existing 10b5-1 Sales Plan arrangements. The filing lists multiple executed or scheduled dispositions by Dawn Maroney, including sales of 100,000 shares on
Alignment Healthcare, Inc. reported proposed and recent sales of its common stock by a trust and an individual in a Form 144 disclosure. The filing lists multiple 10b5-1 plan sales including 180,000 shares on
Alignment Healthcare, Inc. director and CEO John E. Kao reported an open-market sale of 180,000 shares of common stock at a weighted-average price of $18.1864 per share on March 10, 2026. The shares were held indirectly through the JEK Trust, where he serves as trustee. Following the sale, indirect holdings reported for the trust were 2,472,641 shares, and his direct holdings were 1,568,379 shares. The transaction was executed under a Rule 10b5-1 trading plan adopted on March 12, 2025.
JEK TRUST reported a proposed sale of 180,000 shares of Common Stock in a Form 144 filing. The filing lists an aggregate amount of $3,279,600.00 and references NASDAQ trading with a context figure of 204,296,493 shares and the date 03/10/2026.
The excerpt also shows prior 10b5-1 activity by the same trust: sales of 180,000 shares on 02/10/2026 and 01/12/2026 (amounts listed), and an earlier sale of 605,648 shares on 12/29/2025. The filing lists Morgan Stanley Smith Barney LLC in the securities section.
Alignment Healthcare, Inc. reported that Chief Human Resources Officer Andreas P. Wagner sold 21,118 shares of common stock in an open-market transaction on March 4, 2026 at a weighted-average price of $18.6216 per share.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 21, 2025, with individual trade prices ranging from $18.47 to $18.89 per share. Following this transaction, Wagner directly owns 148,687 Alignment Healthcare shares.